SEC Filing: Form DEFA14A
Additional definitive proxy soliciting materials and Rule 14(a)(12) material
VYNE TherapeuticsRooted in Innovation
VYNE Therapeutics
Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Statement of changes in beneficial ownership of securities
Statement of changes in beneficial ownership of securities
Statement of changes in beneficial ownership of securities
Statement of changes in beneficial ownership of securities